Cutaneous necrosis after subcutaneous injection of polyethylene-glycol-modified interferon alpha.
Cutaneous necrosis after subcutaneous injection of polyethylene-glycol-modified interferon alpha.
复制标题
皮下注射聚乙二醇修饰干扰素α后皮肤坏死。
DOI:
10.1080/000155502320323360
复制
发表时间:
2002
影响因子:
3.6
通讯作者:
U. Jappe
中科院分区:
文献类型:
--
作者:
H. Kurzen;D. Petzoldt;W. Hartschuh;U. Jappe
Laboratory examinations revealed leukopenia and anemia, Sir, although thrombocytes, electrolytes, liver enzymes, urea and Interferon-a-2b has been shown to be eVective in the creatinine were within normal range. treatment of hepatitis C and malignant melanoma A skin biopsy was taken from the in ammatory margin of (1, 2). In order to improve treatment comfort and the rst lesion. Microscopic examination revealed dilatation of the vessels with extravasation of erythrocytes, but no signs eYcacy, polyethylene glycol (PEG) modi cation of of vasculitis. The epidermis showed an almost complete interferon-a-2b has recently been introduced. Injection necrosis of the basal layer (Fig. 2a). frequency can thus be reduced from 3 times a week to The second site was removed surgically before complete once a week. We report the development of a cutaneous necrosis had occurred. The epidermis and upper parts of the necrosis (embolia cutis medicamentosa) at the injection dermis were necrotic in a wedge-shaped central part surrounded by vasodilatation. Some of the periadnexial small site after subcutaneous injection of PEG-modi ed vessels were partly occluded due to endothelial swelling. interferon-a-2b in 2 patients with hepatitis C. Lymphocytes were found perivascularly and around the sweat glands. Occlusion of arterial vessels or larger veins was not observed. CASE REPORT